Greenwood-artist Amy Barile poses for a photo by her Koi fish mural in front of a storm drain along Madison Avenue. Barile painted the mural as part of a new city program. Submitted photo Old Town ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Wichita Independent Business ...
BOISE, Idaho — After months of uncertainty, the federal program funding electric vehicle infrastructure across the country will resume. Since 2022, Idaho, among other states, has been in the process ...
SPRINGDALE -- November should see the end of construction work on the latest expansion of the Springdale Public Library. "Right now, our target date is Nov. 1," Anne Gresham, library director, said ...
President Trump signed a proclamation on Friday adding a $100,000 fee to visas for skilled foreign workers. Immigration hard-liners have criticized the program for replacing American workers. By Adeel ...
It was the middle of August, and orientation was wrapping up for new students accepted into the Biosciences Collaborative for Research Engagement (BioCoRE) program, which helps graduate students gain ...
EVERETT — Everett Public Schools officials are working to bring new rigorous course options available for high school students district-wide. Cascade High School is in the process of introducing an ...
WAYZATA, Minn.--(BUSINESS WIRE)-- SUI Group Holdings Limited (“SUI Group,” “SUIG” or the “Company”) (NASDAQ: SUIG), the only publicly traded company with an official relationship with the Sui ...
Oklahoma faces a shortage of anesthesia providers, the university said. According to the Oklahoma Board of Nursing, 52 of the state’s 77 counties do not have an anesthesiologist. At the same time, ...
Fresh off resolving its carriage dispute with Fox, YouTube TV is now in a battle with TelevisaUnivision. The Hispanic media giant has gone live with spots warning its customers that the Google-owned ...
MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results